How Clinique La Prairie Is Keeping Humanity Fashionably Healthy In The Age Of Covid – Forbes

MONTREUX, SWITZERLAND - the Clinique La Prairie facility

Fashion, beauty, health and wellness are all intertwined. You cant really have one without the other

The Clinique La Prairie (CLP) in Montreux, Switzerland has been purveyors of luxury health and wellness for 89 years. This is Switzerlands thing, and one of the main reasons why people travel to the scenic nation of wellness facilities, mountains and natural springs because the country knows and understands the value of health and wellness, especially in this time of Covid. There are facilities like CLP all over Switzerland, with expert and advanced care that offer an intimate luxury environment. For CLP, its their mission to partner with visitors by providing personalized treatment to help and inspire people to live longer, healthier and better lives.

Our vision is always looking at pioneering longevity, says Simone Gibertoni, the CEO of CLP. As the future of wellness is linked to epigenetics, genomics, mental wellness and many more inspiring sciences, we are also taking a particular interest in research on microbiota, senescent cells and their markers, stress and sleep, circadian rhythms- among other aspects of life science and biology, in an effort to determine how they can be used to promote holistic longevity. This approach is envogue and the most fashionable lifestyle implementation that an individual can make in an effort to promote self-longevity.

So, how has this facility overlooking Lake Geneva been able to carry on a mission and vision of world class wellness- with the aim of opening up CLP facilities in Bangkok and Madrid this year, and, other facilities throughout the Middle East, Asia and the Americas in the future? From its inception in 1931 by Professor Paul Niehans, who pioneered development cell therapy, CLP almost ninety years later has continued to expand due to top health and wellness innovations. With fifty specialists, wellness programs that range from immune-boosting and anti-aging revitalization, and luxury hospitality all combined in a state-of-the-art facility, the clinic has been able to grow after all this time and keep people living longer in the process.

MONTREUX, SWITZERLAND - the Clinique La Prairie facility

We believe that health is not only the absence of illness, but the balance of mind, spirit and body, continues Gibertoni.Our guests have the privilege of being accompanied and advised in the ultimate refinement, and benefit from the expertise of leading specialists, from renowned doctors to experts in sport, wellness, and nutrition.

Pioneering health and wellness in the age of covid

As CLP is leading in immunity, they know this is on everyones mind this year, and they are seeing a demand of people wanting revitalization programs, a type of holistic offering that boosts the immune system, while upgrading the mind and body notes Gibertoni. In response to COVID-19, we have introduced new elements to it, including immuno-fortifying ingredients, enhanced nutrition coaching and wellness solutions to help activate the immune function, Gibertoni says. In its one-week approach, Revitalization helps to combat stress and infections and to improve health related setbacks. The Revitalization has been carried out exclusively at CLP for nearly nine decades and does include the CLP Extract, containing biologically active substances, given in conjunction with bio-stimulants.

Recognizing that todays lifestyle can attack the immune system, CLPs MASTER DETOX program provide solutions. Stress, food treated with pesticides, overconsumption and demanding situations like the current one exposes us to a vast quantity of toxins which affect our bodies regeneration capabilities, which can lead to fatigue, digestive problems, allergies or a weakened immune system, says Gibertoni. And in the age of Covid, these negative factors are a need for the body to be eliminated of toxins and promote physiological balance. In this new MASTER DETOX week, we focus on a Cellular Genomic detoxification protocol, in line with our scientific approach, and as always on individual plans based on the four pillars of medical, nutrition, wellbeing and movement.

MONTREUX, SWITZERLAND - the Clinique La Prairie facility offers one-on-one services about the state ... [+] and health of your body and how to increase longevity.

Fashion and beauty start with wellbeing

Gibertoni gives a fitting example of how beauty is birthed out of a good wellbeing regiment.

The first: every health and wellbeing program is also about revealing beauty, because each creates a bespoke path to feel good inside and out. What you eat, your level of stress, your lifestyle habits, your sleep quality, your possible vitamins deficiencies, ... these are all factors very directly impacting beauty.

For example, nutrition based on antioxidants and nutrients that help reduce internal inflammation will support protection against free radical effects and promote hydration. Through individual consultations about longevity, DNA insights, nutrition and movement, and of course body and skin advanced treatments, many factors are addressed in a holistic way during the week program that the guest spends at CLP, leading to help restore healthy foundations and routines, and ultimately boosting radiance.

MONTREUX, SWITZERLAND - the Clinique La Prairie facility offers holistic treatments like massages.

For CLP, revitalization and their MASTER DETOX program has been tried and tested against a radical anti-aging and medical science, so their programs have been able to stand the test of time with their treatments, technologies and coaching that amplify a persons wellbeing.

The most top fashion model, designer, and fashion connoisseur cant have a successful run at fashion without a proper health and wellness regimen, and an occasional visit to a clinic like CLP if they can afford it.

The second dimension is about CLPs cutting-edge programs that focus specifically on anti-aging and regenerative medicine, with an integrative approach to rejuvenation. We help realize the personal journey to look, feel and live well, with cutting edge anti-aging aesthetics protocols for men and women, where all aspects of the body and face are taken into consideration.

MONTREUX, SWITZERLAND - the Clinique La Prairie facility

They do this through stem cell-based programs of the likes of their Beauty Stem Cells and Cell Boast Facelift, where an individuals own stem cells are clinically harvested and re-injected and they also revitalize the skin using natural resources from ones own body to regenerate and slow down aging. All of this results in restoring a persons youthful appearance. Non-invasive aesthetic medicine delivers the latest solutions in the advancing field of preventive and restorative aesthetics. And their 4-5-day beauty holistic programs utilize a holistic approach to beauty by using non-invasive technologies from CLPs anti-aging research.

We all know the latest runway collections are envogue and we all want to look fashionable and have our beauty top notch. What we do for our bodies, from what we put into it and how we treat it will result in our beauty and make us illuminate our various and unique fashion styles. CLP gets people there by going deeper and under the surface by identifying nutritional and lifestyle changes that their visitors need to implement into their lives. All of this leaves people looking radiant, sculpted, balanced and more youthful by the time they leave our facility, as Gibertoni points out and it provides long-lasting effects.

Find out more about Clinique La Prairie in Montreaux and stay tuned for their upcoming new location openings- here.

Read more from the original source:
How Clinique La Prairie Is Keeping Humanity Fashionably Healthy In The Age Of Covid - Forbes

Autologous Fat Grafting Market Scope Analysis 2019 to 2029 – The Think Curiouser

The Most Recent study on the Autologous Fat Grafting Market Research provides a profound comprehension of the various market dynamics like trends, drivers, the challenges, and opportunities. The report further elaborates on the micro and macro-economic elements that are predicted to shape the increase of the Autologous Fat Grafting market throughout the forecast period (2019-2029).

The introduced study elucidates the crucial indicators of Market growth which comes with a thorough analysis of this value chain, CAGR development, and Porters Five Forces Analysis. This data may enable readers to understand the quantitative growth parameters of this international industry that is Autologous Fat Grafting .

Analytical Insights Included from the Autologous Fat Grafting Market Report

Request Sample Report @ https://www.factmr.co/connectus/sample?flag=S&rep_id=2701

Autologous Fat Grafting Market Segmentation Assessment

The increase prospects of this market in various Regions are studied in the report together with details like the regulatory framework, political, and financial outlook of each region.

Competition Landscape

The four leading companies that account for the consolidation of the competition landscape of autologous fat grafting market, continue to represent a whopping 80% share in the revenues. Allergan, MicroAire, Alma Lasers, and Human Med are expected to primarily maintain their strategic focus on partnerships and acquisitions with smaller yet active players. The latter are typically specialized in the development of meniscus repair systems for treating meniscal scars. With this, leading companies operating in autologous fat grafting industry, are eyeing feasibility of entry in the meniscal scars treatment landscape. Increasing strategic tie-ups among manufacturers of systems & accessories, and recognized research institutions, aim to ensure sufficient device supply and superior post-sales service.

Manufacturers in the autologous fat grafting market are also investing efforts in introducing innovative products, to enhance their market shares. For instance, in 2019, Alma Lasers (Sisram Medical) announced the availability of BeautiFill as the novel laser-based technique for fat harvesting, while leveraging autologous fat to restore the volume to body or face. As cellular therapies are increasingly being perceived as mainstream therapeutic option, there has been a surge in demand for adipose derived stem cells (ADSC), which is potentially applicable in tissue engineering and regeneration. Additionally, a growing focus of leading players on introducing advanced systems & accessories is likely to extend applicability of their offerings, leveraging untapped opportunities in the autologous fat grafting market.

For more incisive insights into the autologous fat grafting market, request for the report sample

Key Factors Shaping Autologous Fat Grafting Market

For more intelligence on the autologous fat grafting market, request for the report sample

Key Challenges Facing Autologous Fat Grafting Market

Additional Insight

Biomaterial Research to Open Doors to Multiple Opportunities

Autologous fat grafting technique continues to witness frequent technical modifications. The adoption of autologous fat grafting as a technique to augment and regenerate deficient, irradiated, and aged subcutaneous soft tissue and skin, with minimal complication rate and donor-site morbidity, has grown spectacularly over the recent past. An approach garnering research interests for its potential role in enhancing volumetric retention of fat grafts, involves insertion of autologous platelet-rich fibrin (PRF) into graft tissues. A relevant study indicates PRF as a concentrate that may enhance the outcome of fat grafting for plastic surgery procedures. This newer biomaterial with several potential advantages, such as simpler preparation with no external additive, is likely to trigger new product developments in the autologous fat grafting market.

Autologous Fat Grafting Market Research Methodology

A patented research methodology and a holistic approach form the base of the insightful information provided in the autologous fat grafting market report. This study provides detailed information about the key factors associated with the growth of autologous fat grafting market and presents a systematic breakdown of the factors shaping the progress of market. Detailed primary and secondary research has been done to offer information about the historic and prospective analysis of fat grafting industry, with emphasis on the autologous fat grafting procedure. The report on autologous fat grafting market has also gone through several validation tunnels to guarantee the uniqueness of the insights and key growth influencers, covered in the report.

Request Methodology On This Report @ https://www.factmr.co/connectus/sample?flag=RM&rep_id=2701

The Report intends to eliminate the subsequent doubts regarding the Autologous Fat Grafting market:

Reasons To Choose Fact.MR:

Ask analyst about this report at https://www.factmr.co/connectus/sample?flag=AE&rep_id=2701

Read this article:
Autologous Fat Grafting Market Scope Analysis 2019 to 2029 - The Think Curiouser

X4 Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 5, 2020

BOSTON, Oct. 22, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that it will report its financial results for the third quarter ended September 30, 2020, and provide an update on recent business highlights, on November 5, 2020.

Read more:
X4 Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 5, 2020

Collegium to Host Conference Call to Discuss Third Quarter 2020 Financial Results and Provide Corporate Update

STOUGHTON, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time. The Company will discuss its financial results and provide a corporate update.

Read more:
Collegium to Host Conference Call to Discuss Third Quarter 2020 Financial Results and Provide Corporate Update

Shockwave Medical Announces VIVA20 Investor Update and Conference Call Discussing Third Quarter 2020 Results

SANTA CLARA, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease will webcast an investor update at the virtual VIVA20 on Saturday, November 7 at 11:00 a.m. eastern time. Dr. William Gray, M.D., FACC, FSCAI, Chief of the Division of Cardiovascular Disease at Main Line Health, Wynnewood, PA; Co-Principal Investigator of DISRUPT PAD III will present the results of the PAD III study and then will be joined by Dr. Sarang Mangalmurti, M.D., Interventional Cardiologist and Endovascular Specialist, Bryn Mawr Hospital – Main Line, Doug Godshall, Chief Executive Officer of Shockwave and Keith Dawkins, Chief Medical Officer of Shockwave to discuss the results and answer questions from investors about the study.

Read the original:
Shockwave Medical Announces VIVA20 Investor Update and Conference Call Discussing Third Quarter 2020 Results

Bioasis Announces Analyst Coverage Initiated by Zacks Investment Research

GUILFORD, Conn., Oct. 22, 2020 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that John D. Vandermosten, CFA, Biotechnology Analyst of Zacks Small Cap Research division at Zacks Investment Research and his team (“Zacks”) has initiated analyst coverage on Bioasis Technologies Inc.

Read the original post:
Bioasis Announces Analyst Coverage Initiated by Zacks Investment Research

Theratechnologies to Present at Upcoming Investor Conferences on October 29 and November 10, 2020

MONTREAL, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that management will be presenting at the following upcoming virtual investor conferences.

Go here to see the original:
Theratechnologies to Present at Upcoming Investor Conferences on October 29 and November 10, 2020